Latest Breaking News On - Metagenomi daily - Page 1 : vimarsana.com

Metagenomi (NASDAQ:MGX) Shares Down 5 6%

Metagenomi, Inc. (NASDAQ:MGX – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $6.05 and last traded at $6.05. 20,536 shares were traded during mid-day trading, a decline of 85% from the average session volume of 140,023 shares. The stock had previously closed at $6.41. Wall Street Analyst Weigh […]

United statesFarallon capital managementMetagenomi incArtal groupVanguard group incHhlr advisorsJpmorgan chase coWells fargo companyGet free reportCapital managementVanguard groupMetagenomi daily

Metagenomi s (MGX) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $10.00 price objective on the stock. HC Wainwright also issued estimates for Metagenomi’s Q2 2024 earnings at ($0.69) EPS, Q3 2024 earnings at ($0.71) […]

United statesVanguard group incWells fargo companyJefferies financial groupMetagenomi company profileHhlr advisorsJpmorgan chase coArtal groupAltitude crest partners incMetagenomi incFree reportModerate buyAltitude crest partnersGet free reportMetagenomi daily

JPMorgan Chase & Co Lowers Metagenomi (NASDAQ:MGX) to Neutral

JPMorgan Chase & Co. lowered shares of Metagenomi (NASDAQ:MGX – Free Report) from an overweight rating to a neutral rating in a report published on Thursday, MarketBeat.com reports. They currently have $6.00 target price on the stock, down from their prior target price of $16.00. A number of other equities research analysts have also issued […]

United statesJpmorgan chase coJefferies financial groupMetagenomi incHoldingsas novoWells fargo companyFree reportFinancial groupChardan capitalModerate buyGet free reportMetagenomi dailyNasdaq mgxJpmorgan chase co

Metagenomi (NASDAQ:MGX) Cut to Neutral at JPMorgan Chase & Co

JPMorgan Chase & Co. cut shares of Metagenomi (NASDAQ:MGX – Free Report) from an overweight rating to a neutral rating in a research report report published on Thursday morning, MarketBeat.com reports. They currently have $6.00 price objective on the stock, down from their previous price objective of $16.00. Several other brokerages also recently commented on […]

United statesSecurities exchange commissionJpmorgan chase coJefferies financial groupMetagenomi incWells fargo companyHoldingsas novoFree reportFinancial groupWells fargoModerate buyExchange commissionGet free reportMetagenomi dailyNasdaq mgxJpmorgan chase co

Metagenomi, Inc (NASDAQ:MGX) Receives Average Recommendation of Buy from Analysts

Metagenomi, Inc (NASDAQ:MGX) Receives Average Recommendation of Buy from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMetagenomi company profileSecurities exchange commissionWells fargo companyHoldingsas novoJpmorgan chase coJefferies financial groupMetagenomi incGet free reportFinancial groupChardan capitalExchange commissionGet freeMetagenomi daily